Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
2004 1
2006 1
2008 1
2009 1
2015 1
2018 1
2019 3
2020 4
2021 4
2022 7
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Direct (New) Oral Anticoagulants (DOACs): Drawbacks, Bleeding and Reversal.
Karcioglu O, Zengin S, Ozkaya B, Ersan E, Yilmaz S, Afacan G, Abuska D, Hosseinzadeh M, Yeniocak S. Karcioglu O, et al. Among authors: ersan e. Cardiovasc Hematol Agents Med Chem. 2022;20(2):103-113. doi: 10.2174/1871525719666210914110750. Cardiovasc Hematol Agents Med Chem. 2022. PMID: 34521332 Review.
Severe Fatigue in the First Year Following SARS-CoV-2 Infection: A Prospective Cohort Study.
Verveen A, Wynberg E, van Willigen HDG, Boyd A, de Jong MD, de Bree G, Davidovich U, Lok A, Moll van Charante EP, Knoop H, Prins M, Nieuwkerk P; RECoVERED Study Group. Verveen A, et al. Open Forum Infect Dis. 2022 Apr 10;9(5):ofac127. doi: 10.1093/ofid/ofac127. eCollection 2022 May. Open Forum Infect Dis. 2022. PMID: 35415196 Free PMC article.
A single mRNA vaccine dose in COVID-19 patients boosts neutralizing antibodies against SARS-CoV-2 and variants of concern.
van Gils MJ, van Willigen HDG, Wynberg E, Han AX, van der Straten K, Burger JA, Poniman M, Oomen M, Tejjani K, Bouhuijs JH, Verveen A, Lebbink R, Dijkstra M, Appelman B, Lavell AHA, Caniels TG, Bontjer I, van Vught LA, Vlaar APJ, Sikkens JJ, Bomers MK, Russell CA, Kootstra NA, Sanders RW, Prins M, de Bree GJ, de Jong MD; RECoVERED Study Group. van Gils MJ, et al. Cell Rep Med. 2021 Dec 14;3(1):100486. doi: 10.1016/j.xcrm.2021.100486. eCollection 2022 Jan 18. Cell Rep Med. 2021. PMID: 35103254 Free PMC article.
Health-related quality of life among persons with initial mild, moderate, and severe or critical COVID-19 at 1 and 12 months after infection: a prospective cohort study.
Verveen A, Wynberg E, van Willigen HDG, Davidovich U, Lok A, Moll van Charante EP, de Jong MD, de Bree G, Prins M, Knoop H, Nieuwkerk PT; RECoVERED Study Group. Verveen A, et al. BMC Med. 2022 Nov 2;20(1):422. doi: 10.1186/s12916-022-02615-7. BMC Med. 2022. PMID: 36324167 Free PMC article.
Improving indicator-condition guided testing for HIV in the hospital setting (PROTEST 2·0): A multicenter, interrupted time-series analysis.
Bogers SJ, Schim van der Loeff MF, Boyd A, Davidovich U, van der Valk M, Brinkman K, Sigaloff K, Branger J, Bokhizzou N, de Bree GJ, Reiss P, van Bergen JEAM, Geerlings SE; HIV Transmission Elimination AMsterdam (H-TEAM) Initiative. Bogers SJ, et al. Lancet Reg Health Eur. 2022 Oct 7;23:100515. doi: 10.1016/j.lanepe.2022.100515. eCollection 2022 Dec. Lancet Reg Health Eur. 2022. PMID: 36246146 Free PMC article.
26 results